ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,805 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZurichEndogena Therapeutics AG
Endogena Therapeutics AG Logo
Verified· 3 sources

Endogena Therapeutics AG

Summary

About the company

The core activity of Endogena Therapeutics is the development of therapies to repair damaged tissue by activating the body's own regenerative capabilities. To achieve this, the company combines artificial intelligence with years of experience in drug development to identify small molecules that can specifically activate the body's own stem cells. A key focus is on the development of therapies for inherited blindness and other degenerative diseases.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Development of endogenous regenerative medicines
Development of first-in-class endogenous regenerative drugs for the repair and regeneration of tissues and organs, based on small molecules and selective activation of endogenous cells.
Drug discovery and development for degenerative diseases
Drug discovery and development with a focus on indications with a high unmet medical need, in particular degenerative diseases related to aging and genetic disorders.
Development of therapies for retinal diseases
Development of therapeutic approaches for degenerative eye diseases, in particular retinitis pigmentosa and age-related macular degeneration, with clinical development and studies.
Development of therapies for idiopathic pulmonary fibrosis
Development of a drug program for idiopathic pulmonary fibrosis, a chronic, progressive lung disease with a high unmet medical need.
Press

Media

February 16, 2024Media
Schweizer Forscher macht Blinde sehend
blick.ch
November 28, 2022Media
Neue Wege im Kampf ums Augenlicht
blick.ch

Knowledge

No knowledge articles yet

Once Endogena Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Endogena Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Endogena Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Endogena Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Binzmühlestrasse 170d
8050 Zurich

At a glance

Legal form
Corporation
UID
CHE-243.507.320
Founded
2020 · 6 years
Last commercial register change
August 13, 2024
Employees
11 to 20

Similar companies

SA
Stallergenes AG
Dietlikon
PL
Prometheus Life Technologies AG
Dübendorf
RA
Redbiotec AG
Schlieren
SB
Seito Biologics AG
Küsnacht Zh